<html>
  <head>
    <title></title>
    <!-- Licensed to: K&L Gates LLO
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zd383818db91d4e57813d6f1e49bcaf61">

          <tr>
            <td style="width: 100%; border-bottom: 4px double rgb(0, 0, 0);">
              <div>&#160;
                <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">As filed with the Securities and Exchange Commission on September 4, 2020</div>
                <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><font style="font-size: 10pt; font-weight: bold;">Registration No. 333- </font></div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="margin: 0px 216pt 6pt; font-size: 12pt; font-weight: bold; text-align: center;"> Washington, D.C. 20549</div>
    <div style="margin: 0px 216pt 0px; font-size: 12pt; font-weight: bold; text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 50%; color: #000000;"></div>
    <div style="margin: 6pt 0px 0px; font-size: 18pt; font-weight: bold; text-align: center;"> Form S-8</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="margin: 0px 0px 6px; font-size: 12pt; font-style: italic; font-weight: bold; text-align: center;"> THE SECURITIES ACT OF 1933</div>
    <div style="margin: 0px 0px 6px; font-size: 12pt; font-style: italic; font-weight: bold; text-align: center;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 18%; color: #000000;"></div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">IRADIMED CORPORATION</div>
    <div style="margin: 0px 0px 6pt; font-weight: bold; text-align: center;">(Exact name of registrant as specified in its charter)</div>
    <div style="text-align: center; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 18%; color: #000000;"></div>
    <div style="text-align: center; font-weight: bold;"><font style="font-size: 12pt;"> </font> </div>
    <div style="font-size: 8pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z30a0c40d74b14ef7bbd0945f3d5a8ce2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-weight: bold;">74-1408526</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt; font-weight: bold;">(State or other jurisdiction of</div>
            <div style="text-align: center; font-size: 8pt; font-weight: bold;">incorporation or organization)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-size: 8pt; font-weight: bold;">(I.R.S. Employer</div>
            <div style="text-align: center; font-size: 8pt; font-weight: bold;">Identification No.)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">&#160;</td>
          <td style="width: 50%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="2">
            <div style="text-align: center; font-weight: bold;">1025 Willa Springs Drive</div>
            <div style="text-align: center; font-weight: bold;">Winter Springs, FL&#160; 32708</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="2">
            <div style="margin: 0px 0px 6pt; text-align: center;"><font style="font-size: 8pt; font-weight: bold;">(Address of principal executive offices)</font>&#160;<font style="font-size: 8pt; font-weight: bold;">(Zip Code)</font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">Amended and Restated</div>
    <div style="text-align: center; font-weight: bold;">Iradimed Corporation</div>
    <div style="text-align: center; font-weight: bold;">2014 Equity Incentive Plan</div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;"> <br>
    </div>
    <div style="margin: 0px 0px 6pt; font-size: 8pt; font-style: italic; font-weight: bold; text-align: center;">(Full title of the Plans) </div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
    <br>
    <div style="text-align: center; font-weight: bold;">Chris Scott</div>
    <div style="text-align: center; font-weight: bold;">Corporate Secretary</div>
    <div style="text-align: center; font-weight: bold;">IRADIMED CORPORATION</div>
    <div style="text-align: center; font-weight: bold;">1025 Willa Springs Drive</div>
    <div style="text-align: center; font-weight: bold;">Winter Springs, FL&#160; 32708</div>
    <div style="text-align: center; font-weight: bold;">(407) 677-8022</div>
    <div style="text-align: center; font-size: 8pt; font-weight: bold;">(Name, address and telephone number, including area code, of agent for service)</div>
    <div style="text-align: center; font-size: 8pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-size: 8pt; font-weight: bold;">
      <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
    <div style="border-bottom: 1pt solid black;">
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">&#160;Copies to:</div>
      <div style="text-align: center; font-weight: bold;">Leib Orlanski, Esq.</div>
      <div style="text-align: center; font-weight: bold;">Jacqulyn Lewis, Esq.</div>
      <div style="text-align: center; font-weight: bold;">
        <div style="font-weight: bold;">K&amp;L Gates LLP</div>
        <div style="font-weight: bold;">10100 Santa Monica Blvd., Seventh Floor</div>
        <div style="font-weight: bold;">Los Angeles, CA&#160; 90067</div>
        <div style="font-weight: bold;">(310) 552-5000</div>
        <div style="color: #000000; font-weight: bold;">(310) 552-5001&#160;&#8212; Facsimile</div>
        <div style="color: #000000; font-weight: bold;"> <br>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="margin-bottom: 6pt;"> <br>
      </div>
      <div style="margin-bottom: 6pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160; See the definitions of &#8220;large
        accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b&#8211;2 of the Exchange Act.</div>
      <div style="margin-bottom: 6pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 90%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 19.23%; vertical-align: bottom;">
                <div style="color: #000000;">Large accelerated filer</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
              </td>
              <td style="width: 52.35%; vertical-align: bottom;">&#160;</td>
              <td style="width: 23.29%; vertical-align: bottom;">
                <div style="color: #000000;">Accelerated filer</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 19.23%; vertical-align: bottom;">
                <div style="color: #000000;">Non-accelerated filer</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
              </td>
              <td style="width: 52.35%; vertical-align: bottom;">&#160;</td>
              <td style="width: 23.29%; vertical-align: bottom;">
                <div style="color: #000000;">Smaller reporting company</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 19.23%; vertical-align: bottom;">&#160;</td>
              <td style="width: 2.56%; vertical-align: bottom;">&#160;</td>
              <td style="width: 52.35%; vertical-align: bottom;">&#160;</td>
              <td style="width: 23.29%; vertical-align: bottom;">
                <div style="color: #000000;">Emerging growth company</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div style="text-align: center; color: #000000; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
          Securities Act. &#160;&#9744;</div>
        <div> <br>
        </div>
        <div> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
        <table cellspacing="0" cellpadding="0" id="z73c62348b196412c9e3f2b0c8b9b1d0f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 100%; vertical-align: middle;" colspan="5">&#160;</td>
            </tr>
            <tr>
              <td style="width: 39%; vertical-align: middle;">&#160;</td>
              <td style="width: 13%; vertical-align: middle;">&#160;</td>
              <td style="width: 17%; vertical-align: middle;">&#160;</td>
              <td style="width: 17%; vertical-align: middle;">&#160;</td>
              <td style="width: 14%; vertical-align: middle;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 39%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid;">
                <div>&#160;</div>
                <div style="text-align: center; font-weight: bold;">Title&#160;of&#160;securities</div>
                <div style="text-align: center; font-weight: bold;">to&#160;be&#160;registered</div>
              </td>
              <td style="width: 13%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Amount&#160;to&#160;be</div>
                <div style="text-align: center; font-weight: bold;">registered<sup style="font-family: 'Times New Roman Bold', serif;">(1)</sup></div>
              </td>
              <td style="width: 17%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Proposed&#160;maximum&#160;</div>
                <div style="text-align: center; font-weight: bold;">offering</div>
                <div style="text-align: center; font-weight: bold;">price&#160;per&#160;share</div>
              </td>
              <td style="width: 17%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Proposed&#160;maximum&#160;</div>
                <div style="text-align: center; font-weight: bold;">aggregate</div>
                <div style="text-align: center; font-weight: bold;">offering&#160;price</div>
              </td>
              <td style="width: 14%; vertical-align: bottom; border-left: #000000 1pt solid; border-right: #000000 1pt solid; border-top: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Amount&#160;of</div>
                <div style="text-align: center; font-weight: bold;">registration&#160;fee</div>
              </td>
            </tr>
            <tr>
              <td style="width: 39%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div>Common Stock, $0.0001 par value per share</div>
              </td>
              <td style="width: 13%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">1,000,000<sup>(2)</sup></div>
              </td>
              <td style="width: 17%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">$21.21<sup>(3)</sup></div>
              </td>
              <td style="width: 17%; vertical-align: bottom; border-left: #000000 1pt solid; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">$21,210,000.00</div>
              </td>
              <td style="width: 14%; vertical-align: bottom; border-left: #000000 1pt solid; border-right: #000000 1pt solid; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">$2,753.06</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" id="zb70b055ab42d4bb591e430b25f484fcc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">(1)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of the Registrant&#8217;s Common Stock that become issuable in respect of the
                  securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant&#8217;s receipt of consideration that results in an increase in the number of
                  the outstanding shares of the Registrant&#8217;s Common Stock.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z9492f8c890294ef18b212373ce48b7bd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">(2)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Represents additional shares of Registrant&#8217;s Common Stock reserved for issuance under its Amended and Restated 2014 Equity Incentive Plan as of the date of this Registration Statement.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zf964402432a5454e8f1be551273002ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">(3)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee based on the average of the high and low prices of the Registrant&#8217;s Common Stock as reported on the
                  Nasdaq Capital Market on August 31, 2020.&#160;</div>
              </td>
            </tr>

        </table>
        <div style="border-top: 1pt solid black; padding-top: 1pt;">
          <div><br>
          </div>
          <div style="text-align: center; font-size: 8pt;">&#160;</div>
        </div>
        <div style="text-indent: 24.5pt;"><font style="font-weight: bold;"> </font><br>
        </div>
        <div style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
        <div style="text-align: center; font-weight: bold;">REGISTRATION OF ADDITIONAL SHARES</div>
        <div style="text-align: center; font-weight: bold;">PURSUANT TO GENERAL INSTRUCTION E</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">Pursuant to General Instruction E of Form S-8, Iradimed Corporation. (&#8220;Registrant&#8221;) is filing this Registration Statement with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) to register
          1,000,000 additional shares of Common Stock under the Registrant&#8217;s Amended and Restated 2014 Equity Incentive Plan (the &#8220;Plan&#8221;), pursuant to the provisions of the Plan. This Registration Statement hereby incorporates by reference the contents of
          the Registrant&#8217;s registration statements on Form S-8 filed with the SEC on September 26, 2014 (Registration No. 333-198971). In accordance with the instructional note to Part I of Form S-8 as promulgated by the SEC, the information specified by
          Part I of Form S-8 has been omitted from this Registration Statement.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">PART II</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">Information Required in the Registration Statement</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="z79bec5d1fa0443db9664d680929f960b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;3.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Incorporation of Documents by Reference.</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">The following documents, which have been filed with the SEC by the Registrant, pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the
          &#8220;Exchange Act&#8221;), as applicable, are hereby incorporated by reference in, and shall be deemed to be a part of, this Registration Statement:</div>
        <table cellspacing="0" cellpadding="0" id="zf672fbdaa48a41148d46554efa730ed9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

            <tr>
              <td style="width: 27pt;"><br>
              </td>
              <td style="width: 45pt; vertical-align: top; align: right;">(a)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as filed on March 6, 2020;</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zaccc2fc2d1614f55bc7f0c8376587dcc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

            <tr>
              <td style="width: 27pt;"><br>
              </td>
              <td style="width: 45pt; vertical-align: top; align: right;">(b)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>all other reports filed by the Registrant pursuant to Section&#160;13(a)&#160;or 15(d)&#160;of the Exchange Act since the end of the fiscal year covered by the annual report referred to in (a)&#160;above (in each case, except for the information furnished
                  under Items 2.02 or 7.01 in any current report on Form&#160;8-K); and</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z775b0f83b4b049c295c90b1fc87706b9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

            <tr>
              <td style="width: 27pt;"><br>
              </td>
              <td style="width: 45pt; vertical-align: top; align: right;">(c)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the description of our common stock contained in our Registration Statement on Form 8-A (File No. 001-36534) filed with SEC on July 10, 2014, including any amendment or report filed for the purpose of updating such description.</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement
          and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be
          incorporated by reference herein and to be a part hereof from the date of filing of such documents.</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be
          deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to
          be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; margin-bottom: 12pt;">superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement, except as to specific section of such statements as set forth therein.</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">You should rely only on the information provided or incorporated by reference in this registration statement or any related prospectus. The Registrant has not authorized
          anyone to provide you with different information. You should not assume that the information in this registration statement or any related prospectus is accurate as of any date other than the date on the front of the document.</div>
        <table cellspacing="0" cellpadding="0" id="z3fa3a4c7f28d4fa897a61f07b1499329" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;4.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Description of Securities.</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="text-indent: 24.5pt; margin-bottom: 12pt;">Not applicable.</div>
        <table cellspacing="0" cellpadding="0" id="z11827f2a79014c9a833c950b3cab65db" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;5.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Interests of Named Experts and Counsel.</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="text-indent: 24.5pt; margin-bottom: 12pt;">Not applicable.</div>
        <table cellspacing="0" cellpadding="0" id="z502b385a9e0547e5b1eb99d37a85cdd2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;6.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Indemnification of Directors and Officers.</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="margin: 0px 0px 12pt; text-align: justify; text-indent: 24.5pt;">Section 102 of the General Corporation Law of the State of Delaware permits a corporation to eliminate the personal liability of directors of a corporation to the
          corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except for breaches of the director's duty of loyalty to the corporation or its stockholders, acts or omissions not in good faith or which involve
          intentional misconduct or a knowing violation of a law, authorizations of the payments of a dividend or approval of a stock repurchase or redemption in violation of Delaware corporate law or for any transactions from which the director derived an
          improper personal benefit. Our certificate of incorporation provides that no director will be liable to us or our stockholders for monetary damages for breach of fiduciary duties as a director, subject to the same exceptions as described above.
          We also expect to maintain standard insurance policies that provide coverage (1) to our directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act and (2) to us with respect to indemnification
          payments we may make to such officers and directors.</div>
        <div style="margin: 0px 0px 12pt; text-align: justify; text-indent: 24.5pt;">Section 145 of the General Corporation Law of the State of Delaware provides that a corporation has the power to indemnify a director, officer, employee, or agent of the
          corporation and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys' fees), judgments, fines, and amounts paid in settlements actually and reasonably incurred by the person
          in connection with a threatened, pending, or completed action, suit or proceeding to which he or she is or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he or she reasonably
          believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the
          right of the corporation, indemnification is limited to expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with defense or settlement of such action or suit and no indemnification shall be made with
          respect to any claim, issue, or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication
          of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. In addition, to the extent that a
          present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit, or proceeding described above (or claim, issue, or matter therein), such person shall be indemnified against
          expenses (including attorneys' fees) actually and reasonably incurred by such person in connection therewith.&#160; Expenses (including attorneys' fees) incurred by an officer or director in defending any civil, criminal, administrative, or
          investigative action, suit, or proceeding may be advanced by the corporation upon receipt of an undertaking by such person to repay such amount if it is ultimately determined that such person is not entitled to indemnification by the corporation
          under Section 145 of the General Corporation Law of the State of Delaware.</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 6pt;">The Registrant&#8217;s certificate of incorporation provides that it will, to the fullest extent permitted by law, indemnify any person made or threatened to be made a party to an
          action or proceeding by reason of the fact that he or she (or his or her testators or intestate) is or was the Registrant&#8217;s director or officer or serves or served at any other corporation, partnership, joint venture, trust or other enterprise in
          a similar capacity or as an employee or agent at the Registrant&#8217;s request, including service with respect to employee benefit plans maintained or sponsored by the Registrant, against expenses (including attorneys'), judgments, fines, penalties,
          and amounts paid in settlement incurred in connection with the investigation, preparation to defend, or defense of such action, suit, proceeding, or claim. However, the Registrant is not required to indemnify or advance expenses in connection
          with any action, suit, proceeding, claim, or counterclaim initiated by it or on its behalf. The Registrant&#8217;s amended and restated bylaws provide that it will indemnify and hold harmless each person who was or is a party or threatened to be made a
          party to any action, suit, or proceeding by reason of the fact that he or she is or was its director or officer, or is or was serving at its request in a similar capacity of another</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin: 0px 0px 12pt; text-align: justify;">corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans (whether the basis of such action, suit, or proceeding is an action
          in an official capacity as a director or officer or in any other capacity while serving as a director of officer) to the fullest extent authorized by the Delaware General Corporation Law against all expense, liability and loss (including
          attorney's fees, judgments, fines, ERISA excise taxes, or penalties and amounts paid in settlement) reasonably incurred or suffered by such person in connection with such action, suit, or proceeding, and this indemnification continues after such
          person has ceased to be an officer or director and inures to the benefit of such person's heirs, executors, and administrators. The indemnification rights also include the right generally to be advanced expenses, subject to any undertaking
          required under Delaware General Corporation Law, and the right generally to recover expenses to enforce an indemnification claim or to defend specified suits with respect to advances of indemnification expenses.</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">The indemnification rights set forth above are not exclusive of any other right which an indemnified person may have or hereafter acquire under any statute, provision of
          our certificate of incorporation, our bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</div>
        <table cellspacing="0" cellpadding="0" id="z4140fe6d23314da5a3aad5fe63cfc249" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;7.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Exemption from Registration Claimed.</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="text-indent: 24.5pt; margin-bottom: 12pt;">Not applicable.</div>
        <table cellspacing="0" cellpadding="0" id="zce8277f684814e4bb68b63ad11833625" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item&#160;8.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Exhibits</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zc83da9bc825941ab87bbff98c02a8613" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 100%; vertical-align: middle;" colspan="10">&#160;</td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 37.39%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 45.05%; vertical-align: bottom; border-bottom: #000000 1pt solid;" colspan="5">
                <div style="text-align: center; font-weight: bold;">Incorporated by Reference</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Exhibit </div>
                <div style="text-align: center; font-weight: bold;">No.</div>
              </td>
              <td style="width: 37.39%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="font-weight: bold;">Exhibit Title</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Herewith</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Form</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">File No.</div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom; border-top: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">&#160;&#160;&#160;&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: bottom; border-top: #000000 1pt solid; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Date Filed</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1325618/000089843215001246/def14c.htm">4.1</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Amended and Restated Certificate of Incorporation</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">DEF 14C<br>
                </div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">001-36534<br>
                </div>
              </td>
              <td style="width: 2.56%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">October 9, 2015<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1325618/000089843218001013/bylaws.htm">4.2</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Third Amended and Restated Bylaws of the Registrant</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">8-K<br>
                </div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">001-36534</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">September 19, 2018</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1325618/000104746914006083/a2220669zex-4_1.htm">4.3</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Specimen common stock certificate</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: bottom;">&#160;</td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">S-1A</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">&#160;</td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">333-196875</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">&#160;</td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">July 9, 2014</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="consent.htm#Exhibit5.1">5.1</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Opinion of K&amp;L Gates LLP regarding legality of securities being registered</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">
                <div style="text-align: center;">X</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="rsm_consent.htm#Exhibit23.1">23.1</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Consent of RSM US LLP, Independent Registered Public Accounting Firm</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">
                <div style="text-align: center;">X</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="consent.htm#Exhibit5.1">23.2</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Consent of K&amp;L Gates LLP (included in Exhibit 5.1)</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">
                <div style="text-align: center;">X</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="#Exhibit24.1">24.1</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Power of Attorney (included on signature page)</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">
                <div style="text-align: center;">X</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.89%; vertical-align: top;">
                <div style="text-align: center;"><a href="http://www.sec.gov/Archives/edgar/data/1325618/000110465920091108/irmd-20200630xex10d1.htm">99.1</a></div>
              </td>
              <td style="width: 37.39%; vertical-align: top;">
                <div>Amended and Restated Iradimed Corporation 2014 Equity Incentive Plan and the forms of award agreements thereunder</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 8.56%; vertical-align: top;">&#160;</td>
              <td style="width: 1.06%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 12.9%; vertical-align: top;">
                <div style="text-align: center;">10-Q</div>
              </td>
              <td style="width: 1.06%; vertical-align: bottom;">&#160;</td>
              <td style="width: 12.98%; vertical-align: top;">
                <div style="text-align: center;">001-36534</div>
              </td>
              <td style="width: 2.56%; vertical-align: top;">&#160;</td>
              <td style="width: 15.56%; vertical-align: top;">
                <div style="text-align: center;">August 6, 2020</div>
              </td>
            </tr>

        </table>
        <div>
          <div style="font-weight: bold;"><br>
          </div>
        </div>
        <div style="font-family: 'Times New Roman',Times,serif;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Item 9.</td>
                <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold;">
                    <div style="font-weight: bold;">Undertakings.</div>
                  </div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">(a)&#160; &#160;&#160; The undersigned Registrant hereby undertakes:</div>
        <div style="text-align: justify; text-indent: 54pt; margin-bottom: 12pt;">(1)&#160; To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</div>
        <div style="text-align: justify; text-indent: 94.5pt; margin-bottom: 12pt;">(i)&#160; To include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
        <div style="text-align: justify; text-indent: 94.5pt; margin-bottom: 12pt;">(ii)&#160; To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof)
          which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value
          of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the
          aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective Registration Statement; and</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; margin-bottom: 12pt; text-indent: 90pt;">(iii)&#160; To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such
          information in the Registration Statement.</div>
        <div style="text-align: justify; margin-bottom: 12pt;"><u>Provided</u>, <u>however</u>, that paragraphs (a)(1)(i) and (a)(1)(ii), above, do not apply if the Registration Statement is on Form S-8 and the information required to be included in a
          post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration
          Statement.</div>
        <div style="text-align: justify; text-indent: 54pt; margin-bottom: 12pt;">(2)&#160; That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
          relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
        <div style="text-align: justify; text-indent: 54pt; margin-bottom: 12pt;">(3)&#160; To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">(b)&#160; &#160;&#160; The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report
          pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration
          Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and</div>
        <div style="text-align: justify; text-indent: 24.5pt; margin-bottom: 12pt;">(c)&#160; &#160;&#160; Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant
          pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
          that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or
          proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to
          a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
        <div style="margin-bottom: 12pt;"><br>
        </div>
        <div style="text-indent: 36pt; margin-bottom: 12pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
          S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Winter Springs, State of Florida on this 4th day of September, 2020.&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" id="z405223d86bc64e038aed8b323c75115e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50.72%; vertical-align: top;">
                <div>&#160;</div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div style="font-weight: bold;">IRADIMED CORPORATION</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.72%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 42.12%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.72%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 42.12%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div>/s/ Roger Susi</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.72%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 42.12%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.72%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div>Name:</div>
              </td>
              <td style="width: 42.12%; vertical-align: bottom;">
                <div>Roger Susi</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.72%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 5%; vertical-align: top;">
                <div>Title:</div>
              </td>
              <td style="width: 42.12%; vertical-align: bottom;">
                <div>President, Chief Executive Officer and Chairman of the </div>
                <div>Board of Directors</div>
              </td>
            </tr>

        </table>
        <div style="margin-bottom: 12pt;"><br>
        </div>
        <div style="text-align: right; margin-bottom: 12pt; font-weight: bold;"> Exhibit 24.1<a name="Exhibit24.1"><!--Anchor--></a></div>
        <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">POWER OF ATTORNEY</div>
        <div style="text-indent: 36pt; margin-bottom: 12pt;">We, the undersigned directors and officers of IRADIMED CORPORATION, hereby severally constitute and appoint Roger Susi and Chris Scott, and each of them, our true and lawful attorneys-in-fact and
          agents, with full power of substitution and re-substitution for him or her and in his or her name, place, and stead, in any and all capacities, to sign this Registration Statement of IRADIMED CORPORATION, and any or all amendments thereto
          (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them,
          full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as we might or could do in person, hereby ratifying and confirming all that
          each of said attorney-in-fact, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
        <div style="text-indent: 36pt; margin-bottom: 12pt;">Pursuant to the requirements of the Securities Act, of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</div>
        <table cellspacing="0" cellpadding="0" id="ze9b6f68ddc53483c9e53774d39ff6542" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Signature</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Title</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center; font-weight: bold;">Date</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 58.14%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
              <td style="width: 16.06%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">/s/ Roger Susi</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td nowrap="nowrap" style="width: 55.62%; vertical-align: bottom;">
                <div>President, Chief Executive Officer and Chairman of the Board of Directors</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>September 4, 2020</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: top;">
                <div style="text-align: center;">Roger Susi</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: top;">
                <div>(Principal Executive Officer)</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 58.14%; vertical-align: middle;" colspan="2">&#160;</td>
              <td style="width: 16.06%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">/s/ Chris Scott</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: bottom;">
                <div>Chief Financial Officer and Corporate Secretary</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>September 4, 2020</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: top;">
                <div style="text-align: center;">Chris Scott</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: top;">
                <div>(Principal Financial and Accounting Officer)</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 58.14%; vertical-align: middle;" colspan="2">&#160;</td>
              <td style="width: 16.06%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">/s/ Monty Allen</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: bottom;">
                <div>Director</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>September 4, 2020</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: top;">
                <div style="text-align: center;">Monty Allen</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: top;">&#160;</td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 58.14%; vertical-align: middle;" colspan="2">&#160;</td>
              <td style="width: 16.06%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">/s/ Anthony Vuoto</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: bottom;">
                <div>Director</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>September 4, 2020</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: top;">
                <div style="text-align: center;">Anthony Vuoto</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: top;">&#160;</td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: middle;">
                <div>&#160;</div>
              </td>
              <td style="width: 58.14%; vertical-align: middle;" colspan="2">&#160;</td>
              <td style="width: 16.06%; vertical-align: middle;" colspan="2">
                <div>&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: bottom; border-bottom: #000000 1pt solid;">
                <div style="text-align: center;">/s/ James Hawkins</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: bottom;">
                <div>Director</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>September 4, 2020</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.8%; vertical-align: top;">
                <div style="text-align: center;">James Hawkins</div>
              </td>
              <td style="width: 2.52%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 55.62%; vertical-align: top;">
                <div>&#160;</div>
              </td>
              <td style="width: 2.78%; vertical-align: bottom;">
                <div>&#160;</div>
              </td>
              <td style="width: 13.28%; vertical-align: top;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
      </div>
    </div>
    <br>
  </div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "s-8.htm", "secsgml_size_bytes": 75693}]
{"company-data": {"conformed-name": "IRADIMED CORP", "cik": "0001325618", "assigned-sic": "3841", "irs-number": "731408526", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-248613", "film-number": "201161912"}, "business-address": {"street1": "1025 WILLA SPRINGS DR.", "city": "WINTER SPRINGS", "state": "FL", "zip": "32708", "phone": "4076778022"}, "mail-address": {"street1": "1025 WILLA SPRINGS DR.", "city": "WINTER SPRINGS", "state": "FL", "zip": "32708"}}
As filed with the Securities and Exchange Commission on September 4, 2020
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
IRADIMED CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
74-1408526
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1025 Willa Springs Drive
Winter Springs, FL  32708
(Address of principal executive offices)
(Zip Code)
Amended and Restated
Iradimed Corporation
2014 Equity Incentive Plan
(Full title of the Plans)
Chris Scott
Corporate Secretary
IRADIMED CORPORATION
1025 Willa Springs Drive
Winter Springs, FL  32708
(407) 677-8022
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Leib Orlanski, Esq.
Jacqulyn Lewis, Esq.
K&L Gates LLP
10100 Santa Monica Blvd., Seventh Floor
Los Angeles, CA  90067
(310) 552-5000
(310) 552-5001 — Facsimile
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of "large
        accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b–2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☒
Non-accelerated filer
☐
Smaller reporting company
☒
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
          Securities Act.  ☐
CALCULATION OF REGISTRATION FEE
Title of securities
to be registered
Amount to be
registered
(1)
Proposed maximum
offering
price per share
Proposed maximum
aggregate
offering price
Amount of
registration fee
Common Stock, $0.0001 par value per share
1,000,000
(2)
$21.21
(3)
$21,210,000.00
$2,753.06
(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended ("Securities Act"), this Registration Statement shall also cover any additional shares of the Registrant's Common Stock that become issuable in respect of the
                  securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant's receipt of consideration that results in an increase in the number of
                  the outstanding shares of the Registrant's Common Stock.
(2)
Represents additional shares of Registrant's Common Stock reserved for issuance under its Amended and Restated 2014 Equity Incentive Plan as of the date of this Registration Statement.
(3)
Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee based on the average of the high and low prices of the Registrant's Common Stock as reported on the
                  Nasdaq Capital Market on August 31, 2020.
REGISTRATION OF ADDITIONAL SHARES
PURSUANT TO GENERAL INSTRUCTION E
Pursuant to General Instruction E of Form S-8, Iradimed Corporation. ("Registrant") is filing this Registration Statement with the U.S. Securities and Exchange Commission ("SEC") to register
          1,000,000 additional shares of Common Stock under the Registrant's Amended and Restated 2014 Equity Incentive Plan (the "Plan"), pursuant to the provisions of the Plan. This Registration Statement hereby incorporates by reference the contents of
          the Registrant's registration statements on Form S-8 filed with the SEC on September 26, 2014 (Registration No. 333-198971). In accordance with the instructional note to Part I of Form S-8 as promulgated by the SEC, the information specified by
          Part I of Form S-8 has been omitted from this Registration Statement.
PART II
Information Required in the Registration Statement
Item 3.
Incorporation of Documents by Reference.
The following documents, which have been filed with the SEC by the Registrant, pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the
          "Exchange Act"), as applicable, are hereby incorporated by reference in, and shall be deemed to be a part of, this Registration Statement:
(a)
the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as filed on March 6, 2020;
(b)
all other reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the annual report referred to in (a) above (in each case, except for the information furnished
                  under Items 2.02 or 7.01 in any current report on Form 8-K); and
(c)
the description of our common stock contained in our Registration Statement on Form 8-A (File No. 001-36534) filed with SEC on July 10, 2014, including any amendment or report filed for the purpose of updating such description.
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement
          and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be
          incorporated by reference herein and to be a part hereof from the date of filing of such documents.
Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be
          deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to
          be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or
superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement, except as to specific section of such statements as set forth therein.
You should rely only on the information provided or incorporated by reference in this registration statement or any related prospectus. The Registrant has not authorized
          anyone to provide you with different information. You should not assume that the information in this registration statement or any related prospectus is accurate as of any date other than the date on the front of the document.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Directors and Officers.
Section 102 of the General Corporation Law of the State of Delaware permits a corporation to eliminate the personal liability of directors of a corporation to the
          corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except for breaches of the director's duty of loyalty to the corporation or its stockholders, acts or omissions not in good faith or which involve
          intentional misconduct or a knowing violation of a law, authorizations of the payments of a dividend or approval of a stock repurchase or redemption in violation of Delaware corporate law or for any transactions from which the director derived an
          improper personal benefit. Our certificate of incorporation provides that no director will be liable to us or our stockholders for monetary damages for breach of fiduciary duties as a director, subject to the same exceptions as described above.
          We also expect to maintain standard insurance policies that provide coverage (1) to our directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act and (2) to us with respect to indemnification
          payments we may make to such officers and directors.
Section 145 of the General Corporation Law of the State of Delaware provides that a corporation has the power to indemnify a director, officer, employee, or agent of the
          corporation and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys' fees), judgments, fines, and amounts paid in settlements actually and reasonably incurred by the person
          in connection with a threatened, pending, or completed action, suit or proceeding to which he or she is or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he or she reasonably
          believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the
          right of the corporation, indemnification is limited to expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with defense or settlement of such action or suit and no indemnification shall be made with
          respect to any claim, issue, or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication
          of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. In addition, to the extent that a
          present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit, or proceeding described above (or claim, issue, or matter therein), such person shall be indemnified against
          expenses (including attorneys' fees) actually and reasonably incurred by such person in connection therewith.  Expenses (including attorneys' fees) incurred by an officer or director in defending any civil, criminal, administrative, or
          investigative action, suit, or proceeding may be advanced by the corporation upon receipt of an undertaking by such person to repay such amount if it is ultimately determined that such person is not entitled to indemnification by the corporation
          under Section 145 of the General Corporation Law of the State of Delaware.
The Registrant's certificate of incorporation provides that it will, to the fullest extent permitted by law, indemnify any person made or threatened to be made a party to an
          action or proceeding by reason of the fact that he or she (or his or her testators or intestate) is or was the Registrant's director or officer or serves or served at any other corporation, partnership, joint venture, trust or other enterprise in
          a similar capacity or as an employee or agent at the Registrant's request, including service with respect to employee benefit plans maintained or sponsored by the Registrant, against expenses (including attorneys'), judgments, fines, penalties,
          and amounts paid in settlement incurred in connection with the investigation, preparation to defend, or defense of such action, suit, proceeding, or claim. However, the Registrant is not required to indemnify or advance expenses in connection
          with any action, suit, proceeding, claim, or counterclaim initiated by it or on its behalf. The Registrant's amended and restated bylaws provide that it will indemnify and hold harmless each person who was or is a party or threatened to be made a
          party to any action, suit, or proceeding by reason of the fact that he or she is or was its director or officer, or is or was serving at its request in a similar capacity of another
corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans (whether the basis of such action, suit, or proceeding is an action
          in an official capacity as a director or officer or in any other capacity while serving as a director of officer) to the fullest extent authorized by the Delaware General Corporation Law against all expense, liability and loss (including
          attorney's fees, judgments, fines, ERISA excise taxes, or penalties and amounts paid in settlement) reasonably incurred or suffered by such person in connection with such action, suit, or proceeding, and this indemnification continues after such
          person has ceased to be an officer or director and inures to the benefit of such person's heirs, executors, and administrators. The indemnification rights also include the right generally to be advanced expenses, subject to any undertaking
          required under Delaware General Corporation Law, and the right generally to recover expenses to enforce an indemnification claim or to defend specified suits with respect to advances of indemnification expenses.
The indemnification rights set forth above are not exclusive of any other right which an indemnified person may have or hereafter acquire under any statute, provision of
          our certificate of incorporation, our bylaws, agreement, vote of stockholders or disinterested directors or otherwise.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits
Incorporated by Reference
Exhibit
No.
Exhibit Title
Herewith
Form
File No.
Date Filed
4.1
Amended and Restated Certificate of Incorporation
DEF 14C
001-36534
October 9, 2015
4.2
Third Amended and Restated Bylaws of the Registrant
8-K
001-36534
September 19, 2018
4.3
Specimen common stock certificate
S-1A
333-196875
July 9, 2014
5.1
Opinion of K&L Gates LLP regarding legality of securities being registered
X
23.1
Consent of RSM US LLP, Independent Registered Public Accounting Firm
X
23.2
Consent of K&L Gates LLP (included in Exhibit 5.1)
X
24.1
Power of Attorney (included on signature page)
X
99.1
Amended and Restated Iradimed Corporation 2014 Equity Incentive Plan and the forms of award agreements thereunder
10-Q
001-36534
August 6, 2020
Item 9.
Undertakings.
(a)     The undersigned Registrant hereby undertakes:
(1)  To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)  To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)  To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof)
          which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value
          of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the
          aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective Registration Statement; and
(iii)  To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such
          information in the Registration Statement.
Provided
,
however
, that paragraphs (a)(1)(i) and (a)(1)(ii), above, do not apply if the Registration Statement is on Form S-8 and the information required to be included in a
          post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration
          Statement.
(2)  That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
          relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3)  To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b)     The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report
          pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration
          Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and
(c)     Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant
          pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
          that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or
          proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to
          a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form
          S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Winter Springs, State of Florida on this 4th day of September, 2020.
IRADIMED CORPORATION
By:
/s/ Roger Susi
Name:
Roger Susi
Title:
President, Chief Executive Officer and Chairman of the
Board of Directors
Exhibit 24.1
POWER OF ATTORNEY
We, the undersigned directors and officers of IRADIMED CORPORATION, hereby severally constitute and appoint Roger Susi and Chris Scott, and each of them, our true and lawful attorneys-in-fact and
          agents, with full power of substitution and re-substitution for him or her and in his or her name, place, and stead, in any and all capacities, to sign this Registration Statement of IRADIMED CORPORATION, and any or all amendments thereto
          (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them,
          full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as we might or could do in person, hereby ratifying and confirming all that
          each of said attorney-in-fact, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Roger Susi
President, Chief Executive Officer and Chairman of the Board of Directors
September 4, 2020
Roger Susi
(Principal Executive Officer)
/s/ Chris Scott
Chief Financial Officer and Corporate Secretary
September 4, 2020
Chris Scott
(Principal Financial and Accounting Officer)
/s/ Monty Allen
Director
September 4, 2020
Monty Allen
/s/ Anthony Vuoto
Director
September 4, 2020
Anthony Vuoto
/s/ James Hawkins
Director
September 4, 2020
James Hawkins